Affiliation:
1. Department of Transfusion Medicine and Cell Therapy Mie University Hospital Tsu Japan
2. Department of Clinical Laboratory Mie University Hospital Tsu Japan
3. Hematology and Oncology Mie University Graduate School of Medicine Tsu Japan
Abstract
AbstractBackgroundCryoprecipitate (CRY) is widely used for treating acquired hypofibrinogenemia. During our study to determine an optimal preparation method, we noticed that the measurement of fibrinogen concentration in CRY had a risk of overestimation. We analyzed this condition and mechanism.Study Design and MethodsCRY was prepared from fresh frozen plasma (FFP) under four conditions: A, 30 h thawing time, 2 cycles; B, 24 h thawing time, 2 cycles; C, 30 h thawing time, 1 cycle; and D, 24 h thawing time, 1 cycle. Then, fibrinogen concentrations in CRY and cryosupernatant (CS) were measured by the Clauss method.ResultsPurification (CRY/CRY+CS) and recovery (CRY/FFP) rates in CRY prepared under 2‐cycle conditions were higher than those under 1 cycle. However, recovery rates often exceeded 100%, particularly in the case of CRY prepared under A condition, and fibrinogen concentrations calculated by direct measurement were higher than those indirectly calculated from FFP and CS, suggesting an overestimation of fibrinogen values. The level of soluble fibrin monomer complex was considerably higher in CRY prepared under A than under D condition, indicating that CRY adopted a hypercoagulated state. We further found that repeated thawing/freezing increased fibrinogen values as measured by the Clauss method while mechanical vortexing did not.DiscussionOur findings suggest that direct assessment of fibrinogen contents in CRY prepared by repeated freeze–thawing with a longer thawing period presents a higher risk of overestimation. For the purpose of quality control, we propose an alternative method to indirectly estimate fibrinogen concentrations in CRY from those of CS and FFP.
Subject
Hematology,Immunology,Immunology and Allergy